PFM Health Sciences, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001442756

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 81 positions · Total reported value $978.49M · Top-10 concentration 35.1% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.8% · 24 new · 28 cut · 39 exited

Active Share (vs S&P 500): 96.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.9% · vs SPY -7.0% · Prev Value $1.14B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.3% · vs SPY +0.2% · Latest Value $978.49M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, PFM Health Sciences, LP disclosed 81 equity positions with a combined reported value of $978.49M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 35.1% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were ASND ($52.14M), AXSM ($40.95M), XBI ($38.55M). By sector, the heaviest allocations are Health Care 82.7%, Industrials 6.2%. Versus the prior quarter, allocation shifted toward Other (+8.2pp), Technology (+2.2pp) and away from Consumer Staples (-1.2pp), Health Care (-10.2pp).

Versus the prior quarter, PFM Health Sciences, LP opened 24 new positions, trimmed 28 and fully exited 39, a turnover rate of 75.8% of positions. The portfolio's overlap with the prior quarter was 48% of names.

The largest new positions opened in Q3 2026 were XBI ($38.55M), SPY ($24.73M), CNMD ($14.99M).

Of the 39 positions fully exited versus the prior quarter, the largest were PEN ($19.01M), SYK ($17.83M), MTD ($17.05M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • XBI SPDR SERIES TRUST · $38.55M
  • SPY STATE STR SPDR S&P 500 ETF T · $24.73M
  • CNMD CONMED CORP · $14.99M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $14.07M
  • ZBH ZIMMER BIOMET HOLDINGS INC · $13.81M
  • IWM ISHARES TR · $12.59M
  • VEEV VEEVA SYS INC · $11.33M
  • GMAB GENMAB A/S · $11.19M

Fully Exited (vs previous quarter)

  • PEN PENUMBRA INC · prev qtr: $19.01M
  • SYK STRYKER CORPORATION · prev qtr: $17.83M
  • MTD METTLER TOLEDO INTERNATIONAL · prev qtr: $17.05M
  • MRK MERCK & CO INC · prev qtr: $16.33M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $16.24M
  • COO COOPER COS INC · prev qtr: $15.84M
  • ACHC ACADIA HEALTHCARE COMPANY IN · prev qtr: $15.50M
  • ORKA ORUKA THERAPEUTICS INC · prev qtr: $15.12M

Insider Transactions (Form 4)

Latest PFM Health Sciences, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

PFM Health Sciences, LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 96 US equity positions with a combined value of $1.14B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-69012 (status: Approved), registered 2008-04-10
  • Regulatory AUM (Form ADV): $1.27B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 2 hedge funds
  • Website: pfmhealthsciences.com

Portfolio Structure

  • 96 positions · $1.14B reported value (Q2 2026)
  • Top 10 holdings = 34.6% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 5.4%
  • Average position size: $11.89M

Sector Tilt

  • Health Care 92.9%
  • Industrials 5.1%
  • Consumer Staples 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 32 new, 24 added, 40 reduced, 14 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 82.7%
Technology 3.0%
Other 8.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 228.87K $52.14M 5.33%
5.33%
Reduce
2 222.10K $40.95M 4.18%
4.18%
Add
3 244.50K $38.55M 3.94%
3.94%
New
4 69.24K $37.52M 3.83%
3.83%
Add
5 127.29K $32.53M 3.33%
3.33%
Add
6 320.33K $32.06M 3.28%
3.28%
Add
7 25.08K $29.01M 2.96%
2.96%
Reduce
8 204.34K $28.98M 2.96%
2.96%
Reduce
9 741.86K $26.60M 2.72%
2.72%
Add
10 32.42K $24.73M 2.53%
2.53%
New
11 365.57K $24.05M 2.46%
2.46%
Add
12 31.98K $21.59M 2.21%
2.21%
Add
13 102.11K $20.96M 2.14%
2.14%
Reduce
14 88.93K $20.59M 2.10%
2.10%
Reduce
15 51.08K $19.49M 1.99%
1.99%
Reduce
16 43.92K $19.30M 1.97%
1.97%
Reduce
17 49.67K $18.23M 1.86%
1.86%
Reduce
18 176.43K $17.44M 1.78%
1.78%
Add
19 258.82K $17.06M 1.74%
1.74%
Add
20 822.89K $16.57M 1.69%
1.69%
Add
21 499.84K $15.41M 1.57%
1.57%
Reduce
22 324.25K $14.99M 1.53%
1.53%
New
23 28.88K $14.55M 1.49%
1.49%
Reduce
24 116.07K $14.51M 1.48%
1.48%
Add
25 355.25K $14.07M 1.44%
1.44%
New
26 155.43K $13.81M 1.41%
1.41%
New
27 151.82K $13.11M 1.34%
1.34%
Reduce
28 335.10K $12.75M 1.30%
1.30%
Add
29 45.30K $12.59M 1.29%
1.29%
New
30 39.68K $11.33M 1.16%
1.16%
New
31 313.68K $11.19M 1.14%
1.14%
New
32 188.79K $11.03M 1.13%
1.13%
New
33 96.59K $10.98M 1.12%
1.12%
Add
34 36.48K $10.63M 1.09%
1.09%
Reduce
35 169.56K $10.53M 1.08%
1.08%
Add
36 109.55K $10.39M 1.06%
1.06%
Reduce
37 567.10K $10.32M 1.05%
1.05%
Add
38 1.13M $10.26M 1.05%
1.05%
Reduce
39 45.66K $10.12M 1.03%
1.03%
New
40 150.03K $9.82M 1.00%
1.00%
Add
41 578.98K $9.43M 0.96%
0.96%
Add
42 55.08K $9.35M 0.96%
0.96%
Add
43 50.25K $8.54M 0.87%
0.87%
Reduce
44 190.91K $8.52M 0.87%
0.87%
New
45 282.43K $8.22M 0.84%
0.84%
Add
46 344.95K $7.72M 0.79%
0.79%
Add
47 20.28K $7.66M 0.78%
0.78%
Add
48 235.81K $7.64M 0.78%
0.78%
Reduce
49 42.41K $7.56M 0.77%
0.77%
Add
50 127.60K $7.24M 0.74%
0.74%
Reduce

FAQ

What did PFM Health Sciences, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, PFM Health Sciences, LP reported 81 equity positions worth $978.49M in aggregate; its largest disclosed positions were ASND ($52.14M), AXSM ($40.95M), XBI ($38.55M).

How large is PFM Health Sciences, LP's portfolio?

PFM Health Sciences, LP reported $978.49M of long equity holdings across 81 positions as of 2026-Q3. Top-10 holdings account for 35.1% of reported value.

What is PFM Health Sciences, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/pfm-health-sciences/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →